Informed Consent for PSA Testing: An Outpatient Audit  by Gunawardene, Ashok R. & Kitchen, Mark
Abstracts / International Journal of Surgery 8 (2010) 501–578 577Methods: Electronic Personal Assessment Questionnaire (ePAQ) is a vali-
dated tool that evaluates all aspects of pelvic ﬂoor function (urinary, bowel,
vaginal and sexual). This tool was completed by ten patients (9 female)
undergoing SNS for FI before and after the SNS implant. Responsiveness
was calculated using effect size (ES) and standardised response mean
(SRM). A value of¼ 1 suggests high response and value between 0.20 and 1
shows an acceptable response.
Results: The highest pre implantation score was recorded in bowel
continence and bowel quality-of-life. These also showed the largest ES
and SRM values following SNS (bowel continence ES ¼ 2, SRM ¼ 1, QOL
ES ¼ 0.9 SRM ¼ 0.6). Other domains showed little or no improvement.
Global improvement in function was self reported as much better by 2
(20%), somewhat better by 3(30%) and about the same by 5(50%)
patients.
Conclusions: Despite the evidence that SNS improves global pelvic ﬂoor
function in patients with urinary, faecal and sexual function, surprisingly
we were unable to show that in patients with predominantly faecal
incontinence.INFORMED CONSENT FOR PSA TESTING: AN OUTPATIENT AUDIT
Ashok R. Gunawardene, Mark Kitchen. Shefﬁeld Teaching Hospitals
Introduction: Detection and treatment of early prostate cancer through
the use of PSA testing has yet to be proven to reduce mortality from the
disease. In light of this and the impact of positive results on patients’ lives,
men should be making fully informed decisions when they consider
undergoing the test to investigate the possibility of cancer.
Methods: 106 men attending a Urological outpatients department
completed a questionnaire that assessed the level of patients’ aware-
ness of three important facts about PSA testing at the time of their ﬁrst
test.
Results: 75/106 (70.8%, 95% CI ¼ 61.5–78.6) were aware that ‘PSA is
a blood test used in the investigation of prostate cancer’, 56/106 (52.8%,
95% CI ¼ 43.4–62.1) were aware that ‘having a PSA test is likely to result in
further investigations’ and 34/106 (32.1%, 95% CI ¼ 24.0–41.5) were aware
that ‘PSA is not 100% accurate in the detection of prostate cancer’. 27/106
(25.5%, 95% CI ¼ 18.1–34.5%) were aware of all three facts.
Conclusions: Levels of informed consent were found to be unsatisfactory
in this audit. This ﬁnding conﬁrms the need for more care to be taken in
adequately counselling patients before allowing them to decide whether
or not to undergo PSA testing.WNT SIGNALLING IN ADULT STEM CELLS
Shahab Dadbin. Biomedical tissue research laboratory York Univeristy
Biology department
There is a large body of research evidence supporting the use of mesen-
chymal stem cells (MSCs) derived from human bone marrow for many
therapies. These include cell therapies for degenerative and inherited
diseases. In order to make use of MSCs in these therapies, it is essential to
ﬁnd safe and efﬁcient methods to control their proliferation and differ-
entiation. The Wnt signalling pathway is one of the groups of pathways
which controls proliferation and differentiation in these cells. One of the
subtypes ofWnt signalling pathways is known asWnt/calcium pathway. In
this project Wnt5a ligand was used to investigate some of the effects of
Wnt/calcium signalling pathway in MSCs. It was found that calcium was
released in response to Wnt5a, via intacellular calcium stores. A dose
response curve of Alkaline phosphatise activity was observed duringosteogenic differentiation in response Wnt5a treatment. Date also showed
Wnt5a did not have a proliferative effect in MSCs or during osteogenic
differentiation. Using RT-PCR techniques, genes involved in Wnt/calcium
signalling pathway during osteogenic differentiation were identiﬁed.
Wnt5a was found to be expressed in MSCs, with a reduction in expression
through out osteogenic differentiation.PEER ASSESSMENT FOR EVALUATION OF TECHNICAL SKILLS IN
SURGERY
A. Currie, R. Aggarwal, C. Sugden, T. Lewis, P. Ziprin, A. Darzi. Department
of Biosurgery and Surgical Technology, Imperial College London
Aims: Virtual reality (VR) simulation can enhance patient safety through
early technical skills acquisition outside the operating theatre. However,
optimal methods to evaluate progression are unclear. Expert evaluation,
even via video-analysis, is time-consuming for faculty, and consequently
delays feedback. This study compares novice peer- and self-rating with
expert-rating on a laparoscopic VR simulator.
Methods: 20 paired surgical trainees (F1-ST5) undertook a procedural
task (gall bladder dissection) on the LapMentor VR simulator. The operator
and observer independently scored the procedure using a validated
modiﬁed OSATS scale (total score range 4 to 20). The procedures were
recorded and post-hoc assessed by an expert rater.
Results: Surgical trainees rated themselves more technically proﬁcient
than peer-ratings for total score (median 9.08 versus 12.00, p ¼ 0.046) and
precision (2.17 versus 3.08, p ¼ 0.026), though not for unnecessary
movements, conﬁdence of technique and respect for tissue. Correlation
with expert assessment was superior for peer (r¼ 0.782, p¼ 0.003) versus
self-assessment (r ¼ 0.595, p ¼ 0.041).
Conclusions: Assessment of technical skill by peers is a more suitable
measure of performance than self-assessment, on a simulator task. Peer-
assessment may reduce the need for faculty supervision for competency-
based technical skills training.BREAST CANCER: FIVE-YEAR SURVIVAL AND LOCAL RECURRENCE
RATES FROM A WELSH DGH 2001–2003
O. Jones, V. Srivastava, R. Cochrane, T. Gate. Wrexham Maelor Hospital
Aim: To determine ﬁve-year survival rates for all patients with a new
diagnosis of breast cancer diagnosed during 2001–2003 at a single Welsh
DGH.
Method: All patients diagnosed during 2001–2003 were included. –
Pathology results were analysed to conﬁrm the diagnosis and determine
local recurrence rates. – All deaths recorded were obtained from the
Myrddin computer programme.
Results: 435 patients satisﬁed the inclusion criteria. 11 patients were
excluded due to no record of follow-up. Three patients were male. – Mean
age 62.13 years (Range: 27.67 – 96.79). – Mean follow up 61.85 months
(Range: 0.57 – 100.23). –One and ﬁve-year survival was 92.41% and 73.35%
for all patients. –One and ﬁve-year survival improved to 97.74% and 83.55%
respectively for those having undergone curative surgery for invasive
disease (n ¼ 310). – 8/310 (2.6%) developed a local recurrence during the
follow up period.
Discussion: A period analysis from 2005 predicted a one and ﬁve-year
survival rate of 92.1% and 77.9% for Wales during this period. – The local
recurrence rate reported in this series compares favourably with the
literature.
